Christopher Paul German - 16 Feb 2024 Form 4 Insider Report for RHYTHM PHARMACEUTICALS, INC. (RYTM)

Role
Corporate Controller & CAO
Signature
/s/ Hunter Smith, Attorney-in-Fact for Christopher Paul German
Issuer symbol
RYTM
Transactions as of
16 Feb 2024
Net transactions value
$0
Form type
4
Filing time
21 Feb 2024, 19:02:26 UTC
Previous filing
16 Aug 2023
Next filing
03 Apr 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RYTM Restricted Stock Units Award $0 +7,225 $0.000000 7,225 16 Feb 2024 Common Stock 7,225 Direct F1, F2
transaction RYTM Stock Option (Right to Buy) Award $0 +5,400 $0.000000 5,400 16 Feb 2024 Common Stock 5,400 $49.23 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
F2 The restricted stock units vest as to 25% of the total shares on each of February 16, 2025, February 16, 2026, February 16, 2027 and February 16, 2028. The restricted stock units have no expiration date.
F3 The stock options were granted on February 16, 2024. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date.